In addition, either in primary or metastatic breast cancers, ER-negative/HER2-positive breast cancers have shown poor survival than ER-positive/HER2-positive ones (37), suggesting that the outcome of bone metastatic breast cancer may be dependent on both HR and HER2 statuses of the primary tumor. Here, ESR1 is linked to neoplasm.